• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验性胶质瘤模型中I型干扰素信号在肿瘤细胞与宿主细胞中的不同作用

Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models.

作者信息

Blomberg Evelina, Silginer Manuela, Roth Patrick, Weller Michael

机构信息

Laboratory of Molecular Neuro-Oncology, Department of Neurology, University of Zürich.

Laboratory of Molecular Neuro-Oncology, Department of Neurology, University Hospital Zurich, Zurich, Switzerland.

出版信息

Transl Oncol. 2023 Feb;28:101607. doi: 10.1016/j.tranon.2022.101607. Epub 2022 Dec 24.

DOI:10.1016/j.tranon.2022.101607
PMID:36571986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9800198/
Abstract

Despite multimodal treatment approaches including surgery, radiotherapy and chemotherapy, the median survival for patients with glioblastoma remains in the range of one year and thus poor. Type I interferons (IFN) are involved in immune responses to viral infection and exhibit anti-tumor activity in certain cancers. Here we explored the biological relevance of constitutive type I IFN signaling in murine glioma models in vitro and in vivo. CT-2A, GL-261, SMA-497, SMA-540 and SMA-560 murine glioma cells expressed IFN type I receptors IFNAR1 and IFNAR2 and were responsive to exogenous IFN stimulation. CRISPR/Cas9-mediated deletion of IFNAR1 decreased the baseline expression of type I IFN response genes in GL-261 cells, but neither in CT-2A nor in SMA-560 cells. IFNAR1 deletion slowed growth in GL-261 and SMA-560, but not in CT-2A cells. However, only the growth of IFNAR1-depleted GL-261 tumors and not that of SMA-560 tumors was delayed in vivo upon orthotopic tumor cell implantation into syngeneic mice. This survival gain was no longer detected when the IFNAR1-depleted GL-261 cells were inoculated into IFNAR1-deficient mice. Altogether these data suggest that constitutive type I IFN signaling in gliomas may be pro-tumorigenic, but only in a microenvironment that is proficient for type I IFN signaling in the host.

摘要

尽管采用了包括手术、放疗和化疗在内的多模式治疗方法,但胶质母细胞瘤患者的中位生存期仍在一年左右,因此预后较差。I型干扰素(IFN)参与对病毒感染的免疫反应,并在某些癌症中表现出抗肿瘤活性。在这里,我们在体外和体内的小鼠胶质瘤模型中探讨了组成型I型IFN信号传导的生物学相关性。CT-2A、GL-261、SMA-497、SMA-540和SMA-560小鼠胶质瘤细胞表达I型干扰素受体IFNAR1和IFNAR2,并对外源性IFN刺激有反应。CRISPR/Cas9介导的IFNAR1缺失降低了GL-261细胞中I型IFN反应基因的基线表达,但在CT-2A细胞和SMA-560细胞中均未降低。IFNAR1缺失减缓了GL-261和SMA-560细胞的生长,但对CT-2A细胞没有影响。然而,在将原位肿瘤细胞植入同基因小鼠体内后,只有IFNAR1缺失的GL-261肿瘤的生长延迟,而SMA-560肿瘤的生长没有延迟。当将IFNAR1缺失的GL-261细胞接种到IFNAR1缺陷小鼠中时,不再检测到这种生存获益。总之,这些数据表明,胶质瘤中的组成型I型IFN信号传导可能具有促肿瘤作用,但仅在宿主中I型IFN信号传导功能正常的微环境中如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0147/9800198/46b37b99faee/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0147/9800198/1112327fde13/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0147/9800198/dcee61edac85/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0147/9800198/498645ce4093/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0147/9800198/33b0be3c5e5d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0147/9800198/46b37b99faee/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0147/9800198/1112327fde13/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0147/9800198/dcee61edac85/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0147/9800198/498645ce4093/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0147/9800198/33b0be3c5e5d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0147/9800198/46b37b99faee/gr5.jpg

相似文献

1
Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models.实验性胶质瘤模型中I型干扰素信号在肿瘤细胞与宿主细胞中的不同作用
Transl Oncol. 2023 Feb;28:101607. doi: 10.1016/j.tranon.2022.101607. Epub 2022 Dec 24.
2
Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma.自分泌激活 IFN 信号通路可能促进胶质母细胞瘤的免疫逃逸。
Neuro Oncol. 2017 Oct 1;19(10):1338-1349. doi: 10.1093/neuonc/nox051.
3
IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections.IFNAR2 对于抗流感免疫是必需的,并改变了流感后细菌继发感染的易感性。
Front Immunol. 2018 Nov 9;9:2589. doi: 10.3389/fimmu.2018.02589. eCollection 2018.
4
Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition.免疫和肿瘤内在机制介导放疗和 MET 抑制对实验性脑胶质瘤的协同生长抑制作用。
Acta Neuropathol Commun. 2023 Mar 13;11(1):41. doi: 10.1186/s40478-023-01527-8.
5
Programmed death ligand 1 gene silencing in murine glioma models reveals cell line-specific modulation of tumor growth in vivo.小鼠胶质瘤模型中程序性死亡配体1基因沉默揭示了体内肿瘤生长的细胞系特异性调节。
Neurooncol Adv. 2022 Sep 13;4(1):vdac148. doi: 10.1093/noajnl/vdac148. eCollection 2022 Jan-Dec.
6
CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models.CRISPR/Cas9 介导的 CD95L/CD95 信号通路阻断可抑制神经胶质瘤细胞生长和免疫抑制,从而提高小鼠神经胶质瘤模型的存活率。
J Neurooncol. 2022 Nov;160(2):299-310. doi: 10.1007/s11060-022-04137-x. Epub 2022 Nov 10.
7
Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1.甲型流感病毒的血凝素通过诱导I型干扰素受体1的降解来拮抗I型干扰素(IFN)反应。
J Virol. 2015 Dec 16;90(5):2403-17. doi: 10.1128/JVI.02749-15.
8
IFNAR1 Deficiency Impairs Immunostimulatory Properties of Neutrophils in Tumor-Draining Lymph Nodes.IFNAR1 缺陷削弱肿瘤引流淋巴结中中性粒细胞的免疫刺激特性。
Front Immunol. 2022 Jun 27;13:878959. doi: 10.3389/fimmu.2022.878959. eCollection 2022.
9
Cellular Caspase-3 Contributes to EV-A71 2A-Mediated Down-Regulation of IFNAR1 at the Translation Level.细胞胱冬肽酶-3 有助于肠道病毒 A71 的 2A 蛋白酶介导的干扰素受体 1 在翻译水平的下调。
Virol Sin. 2020 Feb;35(1):64-72. doi: 10.1007/s12250-019-00151-y. Epub 2019 Sep 11.
10
Synthetic mimetics assigned a major role to IFNAR2 in type I interferon signaling.合成模拟物在I型干扰素信号传导中赋予IFNAR2主要作用。
Front Microbiol. 2022 Sep 2;13:947169. doi: 10.3389/fmicb.2022.947169. eCollection 2022.

引用本文的文献

1
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches.表观遗传重塑以提高人类胶质母细胞瘤免疫治疗的疗效:开发新免疫治疗方法的临床前证据。
J Transl Med. 2024 Mar 1;22(1):223. doi: 10.1186/s12967-024-05040-x.
2
Harnessing type I interferon-mediated immunity to target malignant brain tumors.利用 I 型干扰素介导的免疫来靶向恶性脑肿瘤。
Front Immunol. 2023 May 25;14:1203929. doi: 10.3389/fimmu.2023.1203929. eCollection 2023.

本文引用的文献

1
Dual role of ARPC1B in regulating the network between tumor-associated macrophages and tumor cells in glioblastoma.ARPC1B 在调控胶质母细胞瘤中肿瘤相关巨噬细胞与肿瘤细胞之间网络中的双重作用。
Oncoimmunology. 2022 Jan 27;11(1):2031499. doi: 10.1080/2162402X.2022.2031499. eCollection 2022.
2
Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells.内源性干扰素信号传导调节胶质母细胞瘤干细胞的细胞死亡和间充质表型。
Cancers (Basel). 2021 Oct 21;13(21):5284. doi: 10.3390/cancers13215284.
3
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
4
Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response.干扰素在癌症免疫编辑中的作用:塑造转移和免疫治疗反应。
J Clin Invest. 2021 Jan 4;131(1). doi: 10.1172/JCI143296.
5
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.EANO 成人弥漫性胶质瘤诊断与治疗指南。
Nat Rev Clin Oncol. 2021 Mar;18(3):170-186. doi: 10.1038/s41571-020-00447-z. Epub 2020 Dec 8.
6
Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity.干扰素-β暴露诱导出一种脆弱的胶质母细胞瘤干细胞表型,其转录谱显示迁移和丝裂原活化蛋白激酶(MAPK)信号通路活性降低。
Neurooncol Adv. 2020 Mar 28;2(1):vdaa043. doi: 10.1093/noajnl/vdaa043. eCollection 2020 Jan-Dec.
7
Interferons: role in cancer therapy.干扰素:癌症治疗中的作用。
Immunotherapy. 2020 Aug;12(11):833-855. doi: 10.2217/imt-2019-0217. Epub 2020 Jul 7.
8
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.成人脑胶质母细胞瘤:神经肿瘤学会(SNO)和欧洲神经肿瘤学会(EANO)关于当前管理和未来方向的共识综述。
Neuro Oncol. 2020 Aug 17;22(8):1073-1113. doi: 10.1093/neuonc/noaa106.
9
Type I IFN protects cancer cells from CD8+ T cell-mediated cytotoxicity after radiation.I 型干扰素可保护癌细胞免受放射后 CD8+T 细胞介导的细胞毒性作用。
J Clin Invest. 2019 Oct 1;129(10):4224-4238. doi: 10.1172/JCI127458.
10
JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.JCOG0911 INTEGRA 研究:干扰素β联合替莫唑胺对比替莫唑胺单药用于新诊断胶质母细胞瘤的随机筛选 II 期临床试验。
J Neurooncol. 2018 Jul;138(3):627-636. doi: 10.1007/s11060-018-2831-7. Epub 2018 Mar 20.